Tape strips capture atopic dermatitis-related changes in nonlesional skin throughout maturation

Yael Renert-Yuval; Ana B. Pavel; Swaroop Bose; Pedro J. Gómez-Arias; Stephanie M. Rangel; Yeriel D. Estrada; Amy S. Paller; Emma Guttman-Yassky

doi:10.1111/all.15423

Tape strips capture atopic dermatitis-related changes in nonlesional skin throughout maturation

Yael Renert-Yuval, Ana B. Pavel, Swaroop Bose, Pedro J. Gómez-Arias, Stephanie M. Rangel, Yeriel D. Estrada, Amy S. Paller, Emma Guttman-Yassky

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	3445-3447
Number of pages	3
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	77
Issue number	11
DOIs	https://doi.org/10.1111/all.15423
State	Published - Nov 2022

Access to Document

10.1111/all.15423

Cite this

@article{893d8feb958f47479ed0b4267e200660,

title = "Tape strips capture atopic dermatitis-related changes in nonlesional skin throughout maturation",

author = "Yael Renert-Yuval and Pavel, {Ana B.} and Swaroop Bose and G{\'o}mez-Arias, {Pedro J.} and Rangel, {Stephanie M.} and Estrada, {Yeriel D.} and Paller, {Amy S.} and Emma Guttman-Yassky",

note = "Funding Information: Supported by a research grant from the LEO Foundation and Regeneron. Yael Renert‐Yuval was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through Rockefeller University, Grant #UL1TR001866. Funding Information: EGY has served as a consultant for AbbVie, Amgen, Allergan, Asana Bioscience, Celgene, Concert, Dermira, DS Bio‐ pharma, Escalier, Galderma, Glenmark, Kyowa Kirin, LEO Pharmaceuticals, Lilly, Mit‐ subishi Tanabe, Novartis, Pfizer, Regeneron, Sanofi, and Union Therapeutics; a member of advisory boards of Allergan, Asana Bioscience, Celgene, DBV, Dermavant, Dermira, Escalier, Galderma, Glenmark, Kyowa Kirin, LEO Pharma, Lilly, Novartis, Pfizer, Regeneron, and Sanofi; and a recipient of research grants from AbbVie, AnaptysBio, AntibioTx, Asana Bioscience, Boehringer‐Ingelheim, Celgene, DBV, Dermavant, DS Biopharma, Galderma, Glenmark, Innovaderm, Janssen Biotech, Kiniska Pharma, LEO Pharmaceuticals, Lilly, Medimmune, Sienna Biopharmaceuticals, Novan, Novartis, Ralexar, Regeneron, Pfizer, UCB, and Union Therapeutics. ASP has received research support (grants paid to her institution) from AbbVie, Anaptysbio, Celgene, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron. She has been a consultant for Almirall, Amgen, Asana, Boehringer‐Ingelheim, Castle Creek, Celgene, Dermavant, Dermira, Eli Lilly, Exicure, Forte, Galderma, Lenus, Leo, MEDA Corp, Meiji Seika, Novan, Novartis, Pfizer, Regeneron, Sanofi‐Genzyme, and Sol Gel. ASP has served as an investigator (grants to institution) for AbbVie, AnaptysBio, Dermavant, Eli Lilly, Incyte, Janssen, Krystal, Regeneron, UCB; consultant with honorarium for Abbvie, Acrotech, Almirall, Amgen, Amryt, Arcutis, Arena, Azitra, BioCryst, BiomX, Boeringer Ingelheim, Botanix, Bridgebio, Bristol Myers Squibb, Castle Biosciences, Catawba, Eli Lilly, Exicure, Gilead, Incyte, Janssen, Kamari, Leo, Novan, Novartis, Pfizer, Pierre Fabre, RAPT, Regeneron, Sanofi/Genzyme, Seanergy, UCB, and Union, and on the Data Safety Monitoring Board for AbbVie, Abeona, Bausch, Galderma, Inmed, and Novan. All other authors declare no competing interests.",

year = "2022",

month = nov,

doi = "10.1111/all.15423",

language = "English",

volume = "77",

pages = "3445--3447",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11",

}

TY - JOUR

T1 - Tape strips capture atopic dermatitis-related changes in nonlesional skin throughout maturation

AU - Renert-Yuval, Yael

AU - Pavel, Ana B.

AU - Bose, Swaroop

AU - Gómez-Arias, Pedro J.

AU - Rangel, Stephanie M.

AU - Estrada, Yeriel D.

AU - Paller, Amy S.

AU - Guttman-Yassky, Emma

N1 - Funding Information: Supported by a research grant from the LEO Foundation and Regeneron. Yael Renert‐Yuval was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through Rockefeller University, Grant #UL1TR001866. Funding Information: EGY has served as a consultant for AbbVie, Amgen, Allergan, Asana Bioscience, Celgene, Concert, Dermira, DS Bio‐ pharma, Escalier, Galderma, Glenmark, Kyowa Kirin, LEO Pharmaceuticals, Lilly, Mit‐ subishi Tanabe, Novartis, Pfizer, Regeneron, Sanofi, and Union Therapeutics; a member of advisory boards of Allergan, Asana Bioscience, Celgene, DBV, Dermavant, Dermira, Escalier, Galderma, Glenmark, Kyowa Kirin, LEO Pharma, Lilly, Novartis, Pfizer, Regeneron, and Sanofi; and a recipient of research grants from AbbVie, AnaptysBio, AntibioTx, Asana Bioscience, Boehringer‐Ingelheim, Celgene, DBV, Dermavant, DS Biopharma, Galderma, Glenmark, Innovaderm, Janssen Biotech, Kiniska Pharma, LEO Pharmaceuticals, Lilly, Medimmune, Sienna Biopharmaceuticals, Novan, Novartis, Ralexar, Regeneron, Pfizer, UCB, and Union Therapeutics. ASP has received research support (grants paid to her institution) from AbbVie, Anaptysbio, Celgene, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Regeneron. She has been a consultant for Almirall, Amgen, Asana, Boehringer‐Ingelheim, Castle Creek, Celgene, Dermavant, Dermira, Eli Lilly, Exicure, Forte, Galderma, Lenus, Leo, MEDA Corp, Meiji Seika, Novan, Novartis, Pfizer, Regeneron, Sanofi‐Genzyme, and Sol Gel. ASP has served as an investigator (grants to institution) for AbbVie, AnaptysBio, Dermavant, Eli Lilly, Incyte, Janssen, Krystal, Regeneron, UCB; consultant with honorarium for Abbvie, Acrotech, Almirall, Amgen, Amryt, Arcutis, Arena, Azitra, BioCryst, BiomX, Boeringer Ingelheim, Botanix, Bridgebio, Bristol Myers Squibb, Castle Biosciences, Catawba, Eli Lilly, Exicure, Gilead, Incyte, Janssen, Kamari, Leo, Novan, Novartis, Pfizer, Pierre Fabre, RAPT, Regeneron, Sanofi/Genzyme, Seanergy, UCB, and Union, and on the Data Safety Monitoring Board for AbbVie, Abeona, Bausch, Galderma, Inmed, and Novan. All other authors declare no competing interests.

PY - 2022/11

Y1 - 2022/11

UR - http://www.scopus.com/inward/record.url?scp=85133592131&partnerID=8YFLogxK

U2 - 10.1111/all.15423

DO - 10.1111/all.15423

M3 - Letter

C2 - 35775320

AN - SCOPUS:85133592131

SN - 0105-4538

VL - 77

SP - 3445

EP - 3447

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 11

ER -